My role is to aid in the studies of immune toxicity events during immunotherapy. The goal of this research project is to understand the roles of dendritic cells and STAT signaling in regards to the immune-related adverse effects of cancer immunotherapies.
Undergraduate Research Student
I am characterizing the expression of immune factors in a CD103+ Dendritic Cell (DC)-Based Vaccine, which may control its efficacy in a tumor microenvironment. I am further studying the potential of the DC-based vaccine to activate other immune lineages for an anti-tumor response.